ERBB2 and neoplasm: Interestingly, activated DCs pulsed with irrelevant peptide and injected directly into established TUBO tumors suppressed tumor growth to a level between that of untreated mice and those immunized intratumorally with HER-2 CTL peptide-pulsed SFM-DC, initially suggesting that some in vivo killer DC activity was detected.